---
schema_version: "secwatch.filing_event.v1"
accession: "0001144215-22-000071"
form_type: "8-K"
ticker: "AYI"
cik: "0001144215"
company_name: "ACUITY INC. (DE)"
filed_at: "2022-06-30T23:59:59+00:00"
generated_at: "2026-06-24T21:54:14.595668+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Acuity Brands Q3 net sales +18% to $1.1B; diluted EPS $3.07 (+30%); repurchased $405M in shares

## Summary
- Net sales $1.1B (+18% YoY); diluted EPS $3.07 (+30%); adjusted EPS $3.52 (+27%).
- ABL segment sales $1.0B (+18.6%); ISG segment sales $58.3M (+5.2%).
- Repurchased 2.3M shares for $405M in nine months; new $600M credit facility completed.
- Elected Dr. Marcia J. Avedon to Board as independent director, effective June 29, 2022.

## SEC filing metadata
- accession: 0001144215-22-000071
- form_type: 8-K
- ticker: AYI
- cik: 0001144215
- company_name: ACUITY INC. (DE)
- filed_at: 2022-06-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1144215/000114421522000071/0001144215-22-000071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1144215/000114421522000071/ayi-20220629.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001144215-22-000071
- JSON: https://secwatch.observer/filing/0001144215-22-000071.json
- Plain text: https://secwatch.observer/filing/0001144215-22-000071.txt

## Key facts
- Executive change
  Marcia J. Avedon was elected as Director at ACUITY INC. (DE).
  - Action: elected
  - Role: Director
  source text: elected Marcia J. Avedon, Ph.D. to the Board with effect from June 29, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1144215/000114421522000071/0001144215-22-000071-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.